Complex regional pain syndrome type I after infliximab infusion.
Kachko
Ludmyla
L
Efrat
Rachel
R
Ami
Shiri Ben
SB
Katz
Jacob
J
Mukamel
Masha
M
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D020918:Complex Regional Pain Syndromes / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D003424:Crohn Disease / Q000188:drug therapy*; D003937:Diagnosis, Differential; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D008297:Male
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab